반응식
[CH3:1][C:2]1[O:6][N:5]=[C:4]([NH2:7])[N:3]=1.[CH:8]1[C:21]2[CH:20]([C:22](Cl)=[O:23])[C:19]3[C:14](=[CH:15][CH:16]=[CH:17][CH:18]=3)[O:13][C:12]=2[CH:11]=[CH:10][CH:9]=1>>[CH3:1][C:2]1[O:6][N:5]=[C:4]([NH:7][C:22]([CH:20]2[C:21]3[CH:8]=[CH:9][CH:10]=[CH:11][C:12]=3[O:13][C:14]3[C:19]2=[CH:18][CH:17]=[CH:16][CH:15]=3)=[O:23])[N:3]=1참가 물질
3
실험 절차
The title compound, white solid, m.p. 186° C. and MS: m/e=307 (M+) was prepared in accordance with the general method of example 44a from 5-methyl-[1,2,4]oxadiazol-3-ylamine and 9H-xanthene-carboxylic acid chloride.
출처 및 근거
- ORD 기록
- ord-8a64b7eb69724f7f8908fbe3958da578
- 출처 데이터셋
- uspto-grants-2002_10
- 특허 번호
- US06462198B1
연결된 노트
불러오는 중…